How the Framingham 10-Year CVD Risk Score Works
This calculator implements the Framingham General Cardiovascular Disease Risk Score, published by D'Agostino RB Sr. and colleagues in Circulation (2008;117:743-753). It is a point-based system, derived from the long-running Framingham Heart Study, that estimates the probability that a person will have a first "hard" cardiovascular event — heart attack, stroke, heart failure, or peripheral artery disease — within the next 10 years. It uses seven inputs: sex, age, total cholesterol, HDL ("good") cholesterol, systolic blood pressure, whether that blood pressure is treated with medication, current smoking status, and diabetes status. Because it is not a diagnosis, this tool is meant to inform a conversation with a healthcare provider, not replace one.
How the calculation works
Each risk factor is converted into points using sex-specific tables from the original study. Older age, higher total cholesterol, lower HDL, higher systolic blood pressure, smoking, and diabetes all add points; a high HDL level subtracts points because it is protective. Blood pressure earns more points when it is controlled with medication than the same reading achieved without treatment, since needing medication signals a higher underlying risk. The calculator sums all the points, then converts that total into a percentage using the published point-to-risk conversion table — this is the same step-function lookup used in the original research, not a smooth formula, so results jump in increments rather than changing continuously.
Understanding your risk category and next steps
A resulting 10-year risk below 10% is generally considered low, 10-19% is intermediate, 20-29% is high, and 30% or higher is very high, following standard cardiovascular risk stratification conventions. Higher categories typically prompt a closer look at lifestyle factors — diet, exercise, smoking cessation — and a discussion with a clinician about whether cholesterol-lowering or blood-pressure medication is appropriate. This score is educational: it does not know your family history, kidney function, inflammatory markers, or other factors a clinician may weigh.
Limitations of this tool
The score is validated only for adults ages 30-79 and was derived primarily from a White, New England population studied decades ago, so it can under- or over-estimate risk in other populations. Newer tools — the ACC/AHA Pooled Cohort Equations and the 2023 PREVENT equations — are now the guideline-recommended calculators for statin-therapy decisions in US clinical practice and may better reflect contemporary, more diverse populations. Use this calculator for general education and as a conversation starter, and always confirm treatment decisions with a licensed healthcare provider.